Applied Clinical Trials brief examines cortisol influence on GLP-1 response
The roundup also covers epilepsy trial feasibility, family burden in pediatric research, and CRO partnership strategy.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 16 06:35 ETSource: Applied Clinical Trials Online
The wire
- 01Applied Clinical Trials published a brief covering epilepsy trial feasibility, CRO partnerships and cortisol's relationship to GLP-1 response.
- 02Cortisol signals could help explain variation in patient response to GLP-1 therapies.
- 03No underlying data or study details were provided in the item.
From the source
Read at news.google.comACT Brief: Epilepsy Trial Feasibility and Family Realities, CRO Partnerships and Strategic Value, and Cortisol and GLP-1 Response